Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Andrew Armstrong, MD
Man Max 99 years
Andrew Armstrong, MD
Update Il y a 4 ans
The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer
The standard of care for men with metastatic CRPC in 2010 following progression on docetaxel is cabazitaxel or abiraterone acetate/prednisone. Based on results from two other studies, caba...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Andrew Armstrong, MD, ScM
Update Il y a 4 ans
Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
To compare the anti-tumor activity of everolimus and sunitinib in subjects with metastatic renal cell carcinoma (mRCC) with non-clear cell pathology.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD, ScM
Update Il y a 4 ans
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer
This is a single arm study of 11 men with treatment refractory metastatic Castrate Resistant Prostate Cancer (CRPC) who will receive temsirolimus IV at a dose of 25 mg weekly until progres...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD
Update Il y a 4 ans
Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer
This study will examine biomarkers involved in osteomimicry in bone metastases and circulating tumor cells (CTCs) of men with mCRPC before and during therapy with the bone-targeting radiop...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD ScM FACP
Update Il y a 4 ans
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
The purpose of this study is to describe the 2 year progression-free survival in men with recurrent PSA-only disease after prostatectomy receiving combined enzalutamide and standard androg...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD
Update Il y a 4 ans
Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology
This is a minimal risk correlative clinical blood-drawing protocol. The objective of this lead in pilot component is to determine whether Circulating Tumor Cells (CTC's) can be captured us...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD, ScM
Update Il y a 4 ans
BKM120 in Metastatic Castration-resistant Prostate Cancer
The purpose of this study is to evaluate the effects of the study drug, BKM120. The study drug, BKM120, is an inhibitor of a protein called phosphatidyl inositol-3-kinase (PI3K). This prot...
Country
None
organs
None
Specialty
None
Closed trial
More information